Text this: Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

  ______     ___      _  _    __   __            
 /_____//   / _ \\   | \| ||  \ \\/ //     ___   
 `____ `   | / \ ||  |  ' ||   \ ` //     /   || 
 /___//    | \_/ ||  | .  ||    | ||     | [] || 
 `__ `      \___//   |_|\_||    |_||      \__ || 
 /_//       `---`    `-` -`     `-`'       -|_|| 
 `-`                                        `-`